Market Overview:
The global Serotonin Norepinephrine Inhibitor Market is estimated to be valued at US$6.29 billion in 2022. Serotonin Norepinephrine Inhibitors (SNRIs) are pharmaceutical drugs that help regulate the levels of serotonin and norepinephrine neurotransmitters in the brain. These neurotransmitters play a crucial role in mood regulation, pain perception, and stress response.
SNRIs are commonly prescribed for the treatment of major depressive ... Read more
